Prospection & Rock8 Science Partner to Combine Patient-centric Intelligence with Solutions-based Consulting
Prospection and Rock8 Science are proud to announce a preferred partnership in Australia, combining patient-centric intelligence with solutions-based consulting to enable rapid, fact-based decision-making for life sciences organisations.
More and more, pharmaceutical companies are looking for solutions that help bring understanding around the full journey of patients on their brands to achieve full market potential. Prospection has long been the market leader in this space—illuminating patient care’s impact on market share through its patient-centric insights platform. Rock8 Science’s unique, solutions-oriented management consulting leverages this intelligence to help guide brand strategy and action. Together, Prospection and Rock8 Science can give clear direction to clients around their brand’s growth and outcomes opportunities.
“Rock8 is delighted to be working more closely with Prospection. Having used their platform in the past to significant effect, it makes absolute sense to have Prospection as a preferred partner. If you consider the current business planning cycle the industry is currently in, the more facts you have to hand in forming your future projections, the more uncomplicated the conversation, and the stronger your business case. Simply put, facts build trust. Prospection brings that capability at a patient pathway level, identifying opportunities and leakage points that you may not have been aware were affecting your brand’s pre-launch or in-market performance, impacting uptake, growth, patient outcomes, doctor perceptions, and market share. Strategically we can now support our clients in growing their business based on more facts and less assumptions, further differentiating Rock8 Science as a leading solutions-oriented Healthcare Consulting business. ” Charles Heeley, CEO of Rock8 Science.
“Prospection is excited to be able to join forces with Rock8 Science. Rock8 Science brings large volumes of commercial and clinical industry experience that enables them to diagnose organisational and brand-level challenges, and identify opportunities from an objective and unbiased perspective. Moreover, Rock8 Science shares our belief in the significance of data-driven and patient-centred approaches when making critical strategic and investment decisions. This alignment perfectly complements Prospection’s mission. By combining Prospection’s patient-level analytics capabilities with Rock8 Science’s advisory expertise, we are now even more equipped to deliver substantial value to the pharmaceutical industry. Ultimately, our strengthened alliance will have a positive impact on patients’ lives by fostering better outcomes.” Nathan Walters, General Manager ANZ, Prospection.
Contact Prospection for more information.
